Uroplasty (NSDQ:UPI) landed a couple of regional Medicare coverage wins for posterior tibial nerve stimulation treatment of overactive bladder using the company’s neuromodulation device.
Uroplasty Inc.
Diabetes: Medtronic’s Resolute stent performs well in non-diabetics, too | Wall Street Beat
3M touts record sales and earnings per share for 2011 | Earnings Roundup
3M Co. (NYSE:MMM) beat expectations for its 4th-quarter profits and affirmed its guidance for 2012, but Wall Street remained unmoved, with shares staying flat in this morning’s trading.
Greatbatch tramples Wall Street estimates | Earnings Roundup
Greatbatch Inc. (NYSE:GB) shares are up today after the med-tech giant’s third-quarter earnings beat analysts’ expectations.
Clarance, N.Y.-based Greatbatch said third-quarter profits were $6.99 million, or 30 cents a share, on sales of $131 million for the three months ending Sept. 30, up 17.2 percent and 3.3 percent, respectively, compared with the same period last year.
Medtronic incontinence device delivers in trials, Citi analyst cuts company’s share forecast
Medtronic Inc. (NYSE:MDT) got a thumbs up for its InterStim sacral nerve stimulation product’s clinical trials and a thumbs down for the share price forecast for its first quarter.
The Minneapolis, Minn.-based device giant published new data on its InterStim device, showing that it reduced episodes of incontinence and increased quality of life at three years follow-up for a majority of patients.
Boston Scientific reports profit gains and job losses in Q2 | Earnings Roundup
A rebounding Boston Scientific Corp. (NYSE:BSX) said it plans to eliminate up to 1,400 jobs as part of a restructuring program aimed at saving between $225 million to $275 million annually by 2013.
Uroplasty notches yet another reimbursement win
Two more private insurers, representing 13.7 million patients, agreed to cover Uroplasty Inc.’s (NSDQ:UPI) UrgentPC neuromodulation system for urinary incontinence.
Investment update: Russell adds new companies to top U.S. and global equity lists
Uroplasty sets its sights on SUI market vacated by Bard
Uroplasty beats Wall Street, closes near all-time high | Earnings Roundup
Uroplasty Inc. (NSDQ:UPI) beat Wall Street and closed near its all-time high after reporting strong top-line growth for the fourth quarter and full year today.
Another Medicare domino falls for Uroplasty
Uroplasty Inc. (NSDQ:UPI) said it added most of New England to its roster of Medicare carriers after NHIC Corp. agreed to cover its UrgentPC treatment for urinary incontinence, the latest in a series of reimbursement dominoes to topple its way.
The decision, effective May 22 , puts 1.8 million Medicare patients in Maine, Massachusetts, New Hampshire, Rhode Island and Vermont under Uroplasty’s coverage umbrella, for a total of about 31 million in 35 states.